BioCentury
ARTICLE | Clinical News

Balacet 325 propoxyphene napsylate regulatory update

December 6, 2010 8:00 AM UTC

Cornerstone will withdraw its propoxyphene-containing pain drugs at FDA's request after new data showed that propoxyphene increases the risk for serious abnormal heart rhythms. Cornerstone's propoxyph...